Just days after gene editor Tome Biosciences announced undisclosed operational cuts, a clearer picture is coming into focus as 131 employees are being laid off.
https://www.fiercebiotech.com/biotech/preclinical-gene-editor-tome-laying-131-staffers-virtually-entire-workforce